Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT01547052
Other study ID # 1012007764
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date April 2011
Est. completion date September 2016

Study information

Verified date July 2018
Source Weill Medical College of Cornell University
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

I: Conduct Pilot Randomized Clinical Trial of Dialectical Behavior Therapy for children (DBT-C) in residential as compared with Treatment-As-Usual (TAU) (60 children in DBT-C and 60 children in the comparison condition).

II: Finalize therapist training manuals and educational materials to guide selection, training, and supervision of treatment providers.


Description:

Specific Aim 1: Examine feasibility of DBT-C by evaluating response rate in treatment attendance, treatment satisfaction, and any differences in these rates by groups.

Hypothesis 1: DBT-C will be equivalent to TAU in attendance rate and will have significantly greater treatment satisfaction rating by subjects, as well as by therapists and milieu staff.

Specific Aim 2: Examine efficacy of DBT-C as compared to TAU in reducing internalizing and externalizing symptoms.

Hypothesis 2: Children in DBT-C condition as compared to TAU will have significantly fewer internalizing and externalizing symptoms.

Specific Aim 3: Examine efficacy of DBT-C in improving adaptive coping, emotion regulation, risk taking, and social skills, and reducing depression.

Hypothesis 3: Children in DBT-C Training condition as compared to TAU will have significantly greater improvement in adaptive coping skills, emotion regulation, risk taking and impulsivity and social skills, and reducing depressive symptoms.

Specific Aim 4: Examine efficacy of DBT-C in reducing the frequency of critical incidents.

Hypothesis 4: Children in DBT-C condition as compared to TAU will have significantly fewer critical incidents, including psychiatric hospitalization, emergency room visits, total number of days inpatient, suicidal ideations and attempts, self-harm behaviors, sexual acting out, running away, stealing, police involvement, etc.


Recruitment information / eligibility

Status Completed
Enrollment 47
Est. completion date September 2016
Est. primary completion date August 2015
Accepts healthy volunteers No
Gender Male
Age group 6 Years to 12 Years
Eligibility Inclusion Criteria:

- age between 6 years 0 months and 12 years 11 months;

- male;

- in residential care at Green Chimneys;

- projected length of stay is at least 8 months.

Exclusion Criteria:

- pervasive developmental disorder;

- psychotic disorder;

- mental retardation; (all as per psychiatric evaluation at Green Chimneys);

- in care or custody of the Department of Social Services (DSS);

- caregivers do not speak English.

Study Design


Related Conditions & MeSH terms


Intervention

Behavioral:
DBT for children
intervention consists of weekly individual 45 min. sessions, twice per week 60 min. group sessions, and every other week 90 min. sessions with parents
Enhanced Supportive-Educational therapy
weekly individual 45 min sessions, twice per week 60 min. group sessions and every other week parent sessions.

Locations

Country Name City State
United States Green Chimneys Residential Treatment Center Brewster New York

Sponsors (2)

Lead Sponsor Collaborator
Weill Medical College of Cornell University Green Chimneys Residential Treatment Center, Brewster, NY

Country where clinical trial is conducted

United States, 

Outcome

Type Measure Description Time frame Safety issue
Primary Attendance Form post-treatment at 30 weeks
Secondary Balloon Analog Risk Task pre-treatment, week 6, 12, 18, 24, 30 of treatment and at 3 and 6 months follow-up
Secondary Mood and Feelings Questionnaire pre-treatment, weeks 6, 12, 18, 24 and 30 of treatment at at 3 and 6 months follow-up
Secondary Emotion Regulation Checklist pre-treatment, weeks 12, 24 and 30 of treatment at at 3 and 6 months follow-up
Secondary Children's Coping Strategies Checklist pre-treatment, weeks 12, 24 and 30 of treatment at at 3 and 6 months follow-up
Secondary Pleasure Scale for Children pre-treatment, weeks 12, 24 and 30 of treatment at at 3 and 6 months follow-up
Secondary Social Skills Rating Scale pre-treatment, weeks 12, 24 and 30 of treatment at at 3 and 6 months follow-up
Secondary Therapy Satisfaction Questionnaire week 30
Secondary Therapist Satisfaction Scale week 30
Secondary Milieu Staff Satisfaction Questionnaire every 6 months
Secondary Incident Report pre-treatment, weeks 6, 12, 18, 24 and 30 of treatment at at 3 and 6 months follow-up
Secondary Psychosocial Treatment Compliance Scale week 30
Secondary Child Behavior Checklist at pre-treatment, 6, 12, 18, 24, 30 weeks of treatment, and at 3 and 6 months follow-up
Secondary Difficulty with Emotion Regulation Scale pre-treatment
See also
  Status Clinical Trial Phase
Completed NCT02048241 - Intuniv vs Placebo in the Treatment of Childhood Intermittent Explosive Disorder Phase 4